Baker Tilly Wealth Management’s MGM Growth Properties LLC Class A common shares representing limited liability company interests MGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,228
Closed -$318K 541
2022
Q1
$318K Hold
8,228
0.04% 421
2021
Q4
$336K Hold
8,228
0.04% 415
2021
Q3
$315K Sell
8,228
-159
-2% -$6.23K 0.04% 414
2021
Q2
$307K Buy
8,387
+50
+0.6% +$1.78K 0.05% 392
2021
Q1
$272K Buy
8,337
+61
+0.7% +$1.98K 0.06% 382
2020
Q4
$259K Buy
+8,276
New +$247K 0.08% 270

Other funds holding MGP

Baker Tilly Wealth Management's MGP Position: Q2 2022 in Review

Baker Tilly Wealth Management sold out of MGM Growth Properties LLC Class A common shares representing limited liability company interests (MGP) in Q2 2022, closing a stake of 8,228 shares — an estimated $318K sold.

Baker Tilly Wealth Management first reported a position in MGP in Q4 2020 and held it in 6 quarters. The position peaked at $336K in Q4 2021. 1 fund tracked by Wall St. Rank holds MGP as of Q2 2022.

  • Baker Tilly Wealth Management reported no remaining MGM Growth Properties LLC Class A common shares representing limited liability company interests position as of Q2 2022 after selling out during the quarter.
  • Baker Tilly Wealth Management sold 8,228 MGM Growth Properties LLC Class A common shares representing limited liability company interests shares in Q2 2022, an estimated $318K.
  • Baker Tilly Wealth Management first reported a position in MGM Growth Properties LLC Class A common shares representing limited liability company interests in Q4 2020 and held it in 6 quarters.
  • Baker Tilly Wealth Management's MGM Growth Properties LLC Class A common shares representing limited liability company interests position peaked at $336K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held MGM Growth Properties LLC Class A common shares representing limited liability company interests as of Q2 2022.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2022, filed 28 Jul 2022.